| Autor: |
Belinson JL; Department of Obstetrics and Gynecology, University of Vermont, Burlington 05401., Lee KR, Jarrell MA, McClure M |
| Jazyk: |
angličtina |
| Zdroj: |
Gynecologic oncology [Gynecol Oncol] 1990 Apr; Vol. 37 (1), pp. 66-73. |
| DOI: |
10.1016/0090-8258(90)90310-h |
| Abstrakt: |
One-hundred and twenty-four patients with primary advanced (n = 103) and recurrent (n = 21) ovarian carcinoma completed a course of platinum-based chemotherapy (cyclophosphamide/doxorubicin/cisplatin or cyclophosphamide/cisplatin) or developed progressive disease while on therapy and were evaluated. All patients were treated between August 1, 1977 and December 31, 1987. The 5-year survival for patients with primary disease was 27% for stage III (n = 73) and 7% for stage IV (n = 30). The 5-year survival based on residual disease was 91% for microscopic disease (n = 13), 24% for disease less than 2 cm (n = 27), and 8% for disease greater than or equal to 2 cm (n = 64). The 5-year survival for the patients treated with recurrent disease was 5% (n = 21). Borderline tumors have been excluded. Long-term toxicity, including cardiac toxicity, renal toxicity, and a 5% incidence of second primary tumors, is evaluated. |
| Databáze: |
MEDLINE |
| Externí odkaz: |
|
